The choice of Bioequivalence (BE) study design depends on several factors, including the pharmacokinetics (PK) of the drug, its variability, dosage form, and regulatory requirements. Here’s a detailed breakdown of how to select the appropriate BE study design. Standard Two-Way Crossover Design Replicate Crossover Design Parallel Study Design Steady-State BE Study Design Partial Replicate Design…
Today, let’s dive into the intricate world of overcoming solubility challenges in drug formulation. Join me as we explore the hurdles posed by poor solubility and the ingenious strategies formulated by scientists to tackle this pervasive issue. Solubility Challenges Formulation Strategies Nanosuspensions: Solid Dispersions: Cyclodextrin Complexation: Overcoming solubility challenges is pivotal in developing effective therapies….
In pharmaceutical development, FaSSIF and FeSSIF replicate intestinal conditions in fasting and fed states, aiding in predicting drug dissolution, absorption, and bioavailability. FaSSIF (Fasted State Simulated Intestinal Fluid) Purpose: Key Characteristics: Composition: Application: FeSSIF (Fed State Simulated Intestinal Fluid) Purpose: Key Characteristics: Composition: Application: Why Are These Media Important? Biorelevant Dissolution Testing: Food Effect Studies:…
BE studies for clear oral syrup solutions ensure that generic formulations provide the same therapeutic effect as the reference product. Unlike solid dosage forms, oral syrups are already in solution, which simplifies some BE requirements. However, factors such as excipients, solubility, and absorption characteristics can influence the need for in vivo studies. When Are BE…
What is a Discriminatory Medium? A discriminatory medium in biopharmaceutical studies is a dissolution medium that can effectively differentiate between formulations based on their in vitro drug release characteristics. It is designed to highlight differences in formulation, process variables, or drug substance properties that may impact in vivo performance. Why is a Discriminatory Medium Important?…
Pilot BE Study with Two Dosing Strategies To optimize the formulation before the pivotal BE study, two pilot BE studies are conducted with different dissolution behaviors: Strategy 1: Formulation with Matching Dissolution in Discriminating Media Strategy 2: Formulation with Faster or Slower Dissolution (Depending on Dosage Form) Pilot BE Study Strategy Study Design Dosing Strategies:…
